NVO241206P00120000 Option on Novo Nordisk AS

NVO Stock  USD 111.69  2.50  2.29%   
Novo Nordisk's latest option contracts expiring on 2024-12-13 are carrying combined implied volatility of 0.91 with a put-to-call open interest ratio of 0.49 over 78 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-12-13. The total put volume is at 2.2 K, with calls trading at the volume of 2.2 K. This yields a 1.9 put-to-call volume ratio.

Open Interest Against 2024-12-13 Option Contracts

The chart above shows Novo Nordisk's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Novo Nordisk's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Novo Nordisk's option, there is no secondary market available for investors to trade.

Novo Nordisk Maximum Pain Price across 2024-12-13 Option Contracts

Max pain occurs when Novo Nordisk's market makers reach a net positive position across all Novo Nordisk's options at a strike price where option holders stand to lose the most money. By contrast, Novo Nordisk's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Novo Nordisk

Analyzing Novo Nordisk's in-the-money options over time can help investors to take a profitable long position in Novo Nordisk regardless of its overall volatility. This is especially true when Novo Nordisk's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Novo Nordisk's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Novo Nordisk's stock while costing only a fraction of its price.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Please note that buying 'in-the-money' options on Novo Nordisk lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Novo Nordisk's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Novo Nordisk contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Novo Stock moves the wrong way.

Novo Nordisk AS In The Money Call Balance

When Novo Nordisk's strike price is surpassing the current stock price, the option contract against Novo Nordisk AS stock is said to be in the money. When it comes to buying Novo Nordisk's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Novo Nordisk AS are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Novo Current Options Market Mood

Novo Nordisk's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Novo Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Novo Nordisk's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Novo Nordisk's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Novo contract

Base on the Rule 16, the options market is currently suggesting that Novo Nordisk AS will have an average daily up or down price movement of about 0.0569% per day over the life of the 2024-12-13 option contract. With Novo Nordisk trading at USD 111.69, that is roughly USD 0.0635. If you think that the market is fully incorporating Novo Nordisk's daily price movement you should consider buying Novo Nordisk AS options at the current volatility level of 0.91%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Novo Nordisk options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Novo calls. Remember, the seller must deliver Novo Nordisk AS stock to the call owner when a call is exercised.

Novo Nordisk Option Chain

When Novo Nordisk's strike price is surpassing the current stock price, the option contract against Novo Nordisk AS stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Novo Nordisk's option chain is a display of a range of information that helps investors for ways to trade options on Novo. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Novo. It also shows strike prices and maturity days for a Novo Nordisk against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntExpirationCurrent SpreadLast Price
Call
NVO Option Call 13-12-2024 9302024-12-1317.0 - 20.7518.95In
Call
NVO Option Call 13-12-2024 9532024-12-1315.0 - 18.7516.25In
Call
NVO Option Call 13-12-2024 9612024-12-1314.0 - 17.814.96In
Call
NVO Option Call 13-12-2024 9702024-12-1313.0 - 16.814.2In
Call
NVO Option Call 13-12-2024 9912024-12-1312.65 - 14.6511.3In
Call
NVO Option Call 13-12-2024 100872024-12-1311.5 - 12.559.69In
Call
NVO Option Call 13-12-2024 101132024-12-1310.4 - 12.158.3In
Call
NVO Option Call 13-12-2024 1022292024-12-139.8 - 10.6510.35In
Call
NVO Option Call 13-12-2024 103422024-12-138.5 - 10.259.42In
Call
NVO Option Call 13-12-2024 1041052024-12-137.9 - 8.758.65In
Call
NVO Option Call 13-12-2024 1054512024-12-137.15 - 8.07.55In
Call
NVO Option Call 13-12-2024 1061222024-12-136.35 - 6.956.3In
Call
NVO Option Call 13-12-2024 107992024-12-135.55 - 6.255.52In
Call
NVO Option Call 13-12-2024 1081302024-12-134.8 - 5.44.87In
Call
NVO Option Call 13-12-2024 10910962024-12-134.1 - 4.754.1In
Call
NVO Option Call 13-12-2024 11018572024-12-133.55 - 4.23.78In
Call
NVO Option Call 13-12-2024 11113592024-12-133.0 - 3.552.88In
Call
NVO Option Call 13-12-2024 1123872024-12-132.51 - 3.02.7Out
Call
NVO Option Call 13-12-2024 1134612024-12-132.15 - 2.552.4Out
Call
NVO Option Call 13-12-2024 1144922024-12-131.8 - 2.491.8Out
Call
NVO Option Call 13-12-2024 11521502024-12-131.55 - 1.71.69Out
Call
NVO Option Call 13-12-2024 1166862024-12-131.3 - 1.571.37Out
Call
NVO Option Call 13-12-2024 1176442024-12-131.1 - 1.370.77Out
Call
NVO Option Call 13-12-2024 11837042024-12-130.92 - 1.140.92Out
Call
NVO Option Call 13-12-2024 1191622024-12-130.72 - 0.940.7Out
Call
NVO Option Call 13-12-2024 12023972024-12-130.33 - 0.80.66Out
Call
NVO Option Call 13-12-2024 1212732024-12-130.51 - 0.630.54Out
Call
NVO Option Call 13-12-2024 1226512024-12-130.41 - 0.520.45Out
Call
NVO Option Call 13-12-2024 123862024-12-130.28 - 0.440.25Out
Call
NVO Option Call 13-12-2024 1241902024-12-130.26 - 0.370.32Out
Call
NVO Option Call 13-12-2024 12520012024-12-130.16 - 0.310.27Out
Call
NVO Option Call 13-12-2024 126582024-12-130.09 - 0.270.17Out
Call
NVO Option Call 13-12-2024 127262024-12-130.1 - 0.210.13Out
Call
NVO Option Call 13-12-2024 129112024-12-130.0 - 1.330.31Out
Call
NVO Option Call 13-12-2024 1303162024-12-130.01 - 0.20.07Out
Call
NVO Option Call 13-12-2024 1321032024-12-130.02 - 0.090.03Out
Call
NVO Option Call 13-12-2024 1352282024-12-130.0 - 0.080.03Out
Call
NVO Option Call 13-12-2024 13722024-12-130.0 - 1.270.05Out
Call
NVO Option Call 13-12-2024 1401022024-12-130.0 - 0.70.03Out
Call
NVO Option Call 13-12-2024 145722024-12-130.0 - 0.020.05Out
Call
NVO Option Call 13-12-2024 15062024-12-130.0 - 1.270.05Out
Call
NVO Option Call 13-12-2024 16062024-12-130.0 - 1.990.01Out
 Put
NVO Option Put 13-12-2024 75672024-12-130.0 - 0.010.03Out
 Put
NVO Option Put 13-12-2024 801172024-12-130.0 - 0.00.02Out
 Put
NVO Option Put 13-12-2024 853892024-12-130.0 - 0.030.01Out
 Put
NVO Option Put 13-12-2024 89602024-12-130.0 - 0.030.01Out
 Put
NVO Option Put 13-12-2024 904582024-12-130.0 - 0.040.01Out
 Put
NVO Option Put 13-12-2024 931022024-12-130.0 - 0.50.01Out
 Put
NVO Option Put 13-12-2024 94662024-12-130.02 - 0.110.03Out
 Put
NVO Option Put 13-12-2024 9511612024-12-130.01 - 0.10.05Out
 Put
NVO Option Put 13-12-2024 962922024-12-130.0 - 0.060.06Out
 Put
NVO Option Put 13-12-2024 971192024-12-130.0 - 0.20.09Out
 Put
NVO Option Put 13-12-2024 983272024-12-130.07 - 0.160.14Out
 Put
NVO Option Put 13-12-2024 997372024-12-130.09 - 0.190.19Out
 Put
NVO Option Put 13-12-2024 10023552024-12-130.21 - 0.240.2Out
 Put
NVO Option Put 13-12-2024 1011972024-12-130.16 - 0.30.25Out
 Put
NVO Option Put 13-12-2024 1022082024-12-130.27 - 0.390.33Out
 Put
NVO Option Put 13-12-2024 1034592024-12-130.33 - 0.470.4Out
 Put
NVO Option Put 13-12-2024 1044232024-12-130.41 - 0.590.45Out
 Put
NVO Option Put 13-12-2024 1054662024-12-130.55 - 0.730.95Out
 Put
NVO Option Put 13-12-2024 1063682024-12-130.74 - 0.880.82Out
 Put
NVO Option Put 13-12-2024 1071992024-12-130.95 - 1.111.02Out
 Put
NVO Option Put 13-12-2024 1084472024-12-131.17 - 1.351.26Out
 Put
NVO Option Put 13-12-2024 1094282024-12-131.5 - 1.71.65Out
 Put
NVO Option Put 13-12-2024 1102282024-12-131.85 - 2.112.0Out
 Put
NVO Option Put 13-12-2024 1114432024-12-132.21 - 2.632.51Out
 Put
NVO Option Put 13-12-2024 112562024-12-132.72 - 3.13.07In
 Put
NVO Option Put 13-12-2024 11392024-12-133.25 - 3.755.72In
 Put
NVO Option Put 13-12-2024 114192024-12-133.85 - 4.44.0In
 Put
NVO Option Put 13-12-2024 11592024-12-134.5 - 5.14.67In
 Put
NVO Option Put 13-12-2024 116112024-12-135.15 - 6.05.88In
 Put
NVO Option Put 13-12-2024 11732024-12-135.8 - 6.78.2In
 Put
NVO Option Put 13-12-2024 11822024-12-136.6 - 7.518.02In
 Put
NVO Option Put 13-12-2024 11932024-12-137.15 - 9.510.4In
 Put
NVO Option Put 13-12-2024 120302024-12-138.25 - 9.259.8In
 Put
NVO Option Put 13-12-2024 12212024-12-1310.05 - 11.511.95In
 Put
NVO Option Put 13-12-2024 13002024-12-1318.05 - 18.817.8In
 Put
NVO Option Put 13-12-2024 13502024-12-1324.85 - 27.4525.16In

Novo Nordisk Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Novo Nordisk Market Cap Over Time

   Market Cap   
       Timeline  

Novo Total Stockholder Equity

Total Stockholder Equity

111.89 Billion

At this time, Novo Nordisk's Total Stockholder Equity is very stable compared to the past year.

Novo Nordisk Corporate Directors

Kasim KutayDirectorProfile
Sylvie GregoireIndependent DirectorProfile
Mette JensenDirector, Employee RepresentativeProfile
Thomas RantzauDirector, Employee RepresentativeProfile
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.224
Dividend Share
9.9
Earnings Share
2.99
Revenue Per Share
60.698
Quarterly Revenue Growth
0.214
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.